Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-30 Fowler Neal Franklin Director Grant or award +25,344 160,847
2026-04-30 Fowler Neal Franklin Director Grant or award · Stock Option (Right to Buy) +11,296 11,296
2025-04-30 Fowler Neal Franklin Director Grant or award +34,403 135,503
2025-04-30 Fowler Neal Franklin Director Grant or award · Stock Option (Right to Buy) +15,824 41,572
2025-03-12 Fowler Neal Franklin Director Sale −35,000 $5.83 $204K 101,100
2024-05-23 Fowler Neal Franklin Director Grant or award +17,430 136,100
2024-05-23 Fowler Neal Franklin Director Grant or award · Stock Option (Right to Buy) +25,748 25,748
2023-10-03 Fowler Neal Franklin Director Grant or award +118,670 118,670

Page 1 of 1 · 8 trades